Nisterime acetate

From WikiMD's WELLNESSPEDIA

(Redirected from ORF-9326)

Nisterime_acetate.svg

Nisterime acetate is a synthetic glucocorticoid and corticosteroid medication. It is used primarily for its anti-inflammatory and immunosuppressive properties. Nisterime acetate is a derivative of prednisolone, a commonly used corticosteroid.

Pharmacology[edit]

Nisterime acetate works by binding to the glucocorticoid receptor, which leads to a series of cellular events that reduce inflammation and suppress the immune response. This makes it effective in treating a variety of inflammatory and autoimmune conditions.

Medical Uses[edit]

Nisterime acetate is used in the treatment of conditions such as asthma, allergic reactions, rheumatoid arthritis, and inflammatory bowel disease. It is also used in the management of certain skin disorders and to prevent organ rejection in transplant patients.

Side Effects[edit]

Common side effects of nisterime acetate include weight gain, hypertension, osteoporosis, and hyperglycemia. Long-term use can lead to more serious side effects such as adrenal suppression and Cushing's syndrome.

Dosage and Administration[edit]

Nisterime acetate is typically administered orally, but it can also be given via intravenous or intramuscular injection. The dosage varies depending on the condition being treated and the patient's response to the medication.

Mechanism of Action[edit]

Nisterime acetate exerts its effects by modulating the expression of various genes involved in the inflammatory response. It inhibits the production of pro-inflammatory cytokines and promotes the production of anti-inflammatory proteins.

History[edit]

Nisterime acetate was developed as a more potent and longer-acting alternative to prednisolone. It was first synthesized in the mid-20th century and has since been used in various clinical settings.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.